Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Genes|July 28, 2026
From Molecular Classification to Hereditary Cancer Syndrome Identification in Endometrial CancerLaura Libera, Ileana Carnevali, Sofia Facchi, et al.
Tumori|October 25, 2024
PALB2 analysis in the diagnostic process of breast cancer: An Italian monocentric experienceMaria Grazia Tibiletti, Ileana Carnevali, Sofia Facchi, et al.
Genes|November 25, 2023
MLH1 Promoter Methylation Could Be the Second Hit in Lynch Syndrome CarcinogenesisIleana Wanda Carnevali, Giulia Cini, Laura Libera, et al.
Cancer Genetics|March 14, 2023
High frequency of BCL2 gene rearrangement-negative follicular lymphoma in northwestern ItalyFrancesca Magnoli, Deborah Marchiori, Sofia Facchi, et al.
Frontiers in Oncology|October 19, 2023
Similarities and differences in gene expression profiles of BRCA1 methylated and mutated epithelial ovarian cancersNora Sahnane, Laura Libera, Sofia Facchi, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|September 14, 2021
Strategies for Lynch syndrome identification in selected and unselected gynecological cancersIleana Carnevali, Nora Sahnane, Anna Maria Chiaravalli, et al.
Pathology, Research and Practice|February 16, 2024
Immunohistochemical and molecular pattern of p53 in epithelial ovarian cancers negative for germline BRCA1/2 variantsSusanna Ronchi, Sofia Facchi, Eleonora Di Lauro, et al.
Biomedicines|May 28, 2022
OncoPan®: An NGS-Based Screening Methodology to Identify Molecular Markers for Therapy and Risk Assessment in Pancreatic Ductal AdenocarcinomaMaria Grazia Tibiletti, Ileana Carnevali, Valeria Pensotti, et al.
International Journal of Molecular Sciences|December 23, 2020
BRCA Methylation Testing Identifies a Subset of Ovarian Carcinomas without Germline Variants That Can Benefit from PARP InhibitorNora Sahnane, Ileana Carnevali, Giorgio Formenti, et al.
Cancer Prevention Research (Philadelphia, Pa.)|April 17, 2025
From therapy to cancer prevention using HRD testing on high grade ovarian cancer patientsMaria Grazia Tibiletti, Ileana Carnevali, Sofia Facchi, et al.
Pageof 2